Pharma Journalist 9027 posts 0 comments

EnGeneIC Limited, an Australian, Sydney-based biotechnology company, has developed a globally unique nanocellular technology that in pre-clinical animal studies has been shown to…
Read More...

NeuExcell Therapeutics and Spark Therapeutics, a member of the Roche Group announced a gene therapy collaboration aimed at developing a safe and effective treatment for patients…
Read More...

JW Therapeutics an innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, announced that the National Medical Products…
Read More...

SMi Group reports: Conference co-chairs invite aseptic processing experts to join the virtual Aseptic Processing Conference in two weeks The industry is ever changing and with the…
Read More...

GeneQuantum Healthcare (Suzhou) Co.,Ltd. and BrighGene Biomedical (Suzhou) Co.,Ltd. signed a co-development agreement for antibody immune agonist conjugate (AIAC), GQ1007. GQ1007 is…
Read More...

AstraZeneca and the European Commission have reached an agreement that ends legal proceedings over the execution of the Advance Purchase Agreement for the delivery of the COVID-19…
Read More...

Ultomiris (ravulizumab) has been approved in the European Union for expanded use to include children (with a body weight of 10 kg or above) and adolescents with paroxysmal nocturnal…
Read More...

Sorrento Therapeutics, Inc. announced the start of enrollment in its Phase 2 efficacy study of human allogeneic adipose-derived mesenchymal stem cells (COVI-MSC) for patients suffering…
Read More...

Curia, formerly AMRI, a leading contract research, development and manufacturing organization, announced it has completed the transaction to acquire LakePharma Inc., a privately held…
Read More...

Agilent Technologies Inc. announced the signing of a worldwide distribution agreement with Visiopharm, enabling Agilent to co-market Visiopharm’s portfolio of CE-IVD marked artificial…
Read More...